Abstract
This review provides a broad summary of the performance characteristics of high-throughput severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serologic assays with Food and Drug Administration Emergency Use Authorization, which are commonly found in central clinical laboratories. In addition, this review discusses the current roles of serologic testing for SARS-CoV-2 and provides a perspective for the future.
Keywords: Antibody; COVID-19; High-throughput assays; SARS-CoV-2; Serology.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, antibody, Serology., High-throughput assays, 【초록키워드】 coronavirus, drug, Characteristics, serologic testing, food, Emergency, acute respiratory syndrome, Perspective, authorization, serologic assay, addition, provide, 【제목키워드】 review, drug, coronavirus 2, serologic, respiratory, performance, food, Emergency,
【저자키워드】 COVID-19, SARS-CoV-2, antibody, Serology., High-throughput assays, 【초록키워드】 coronavirus, drug, Characteristics, serologic testing, food, Emergency, acute respiratory syndrome, Perspective, authorization, serologic assay, addition, provide, 【제목키워드】 review, drug, coronavirus 2, serologic, respiratory, performance, food, Emergency,
{{{ 추상적인 }}}
이 검토는 중앙 임상 실험실에서 일반적으로 발견되는 FDA 긴급 사용 승인을 통한 고처리량 중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 혈청학적 분석의 성능 특성에 대한 광범위한 요약을 제공합니다. 또한, 이 리뷰는 SARS-CoV-2에 대한 혈청학적 검사의 현재 역할에 대해 논의하고 미래에 대한 전망을 제공합니다.
{{ 키워드: }} 항체; 코로나바이러스감염증-19 : 코로나19; 고처리량 분석; 사스 코로나바이러스 2; 혈청학.